Literature DB >> 3957531

Hepatitis B infection in prostitutes.

C L Goh, V S Rajan, S H Chan, A Kamarudin.   

Abstract

The prevalence of HBV markers in prostitutes is known to be higher than that of the normal population of similar age range in previous studies. This study showed a significant correlation between the duration of prostitution and the prevalence of HBV antibodies amongst the prostitutes. The prevalence of HBV antibodies doubled after the first year of prostitution. A two-year follow-up study of these prostitutes showed that 37% of HBsAg positive prostitutes lost the HBsAg. The seroconversion rate of HBsAg negative prostitutes was 10% during this two-year period. Early immunization against HBV infection should be considered in this high risk group in view of these findings.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957531     DOI: 10.1093/ije/15.1.112

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

1.  [Hepatitis in drug poisonings].

Authors:  K Trübner; K Püschel; R Laufs
Journal:  Z Rechtsmed       Date:  1989

Review 2.  Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia.

Authors:  M A Lansang
Journal:  Gut       Date:  1996       Impact factor: 23.059

3.  Hepatitis B and Delta virus infection among heterosexuals, homosexuals and bisexual men.

Authors:  A Mele; E Franco; F Caprilli; G Gentili; M A Stazi; L Zaratti; B Capitanio; E Crescimbeni; R Corona; A Panà
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

4.  The hepatitis B immunization programme in Singapore.

Authors:  K T Goh; S Doraisingham; K L Tan; C J Oon; M L Ho; A J Chen; S H Chan
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

5.  Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity.

Authors:  B H Heng; K T Goh; R Chan; S K Chew; S Doraisingham; G H Quek
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.